Response to Abemaciclib After 10 Lines of Therapy Including Palbociclib in Metastatic Breast Cancer: A Case Report With Literature Review

Metastatic breast cancer (BC) is considered incurable, and it is generally treated with sequential single-agent therapies to control it with palliative intent. Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) are used in the front-line setting of hormone receptor (HR)-positive, HER2-negative BC, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wender, Isabella O., Haines, Kayla, Jahanzeb, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683665/
https://www.ncbi.nlm.nih.gov/pubmed/32876928
http://dx.doi.org/10.1007/s40487-020-00126-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683665/
https://www.ncbi.nlm.nih.gov/pubmed/32876928
http://dx.doi.org/10.1007/s40487-020-00126-0

Ejemplares similares